<!DOCTYPE html>

<html>
<head>
<meta charset="utf-8"/>
<meta content="width=device-width, initial-scale=1.0" name="viewport"/>
<link href="../../../webpages.css" rel="stylesheet"/>
</head>
<body>
<div class="banner">
<div class="banner-content">
<h1>DermpathNet</h1>
</div>
</div>
<nav>
<a href="../../../index.html" target="_blank">
<text type="button">Home</text>
</a>
<a href="../../../browser-page-317.html" target="_blank">
<text type="button">Browse</text>
</a>
<a href="../../../download-page.html" target="_blank">
<text type="button">Downloads</text>
</a>
<a href="../../../contact-us.html" target="_blank">
<text type="button">About</text>
</a>
</nav>
<footer class="site-footer">
<p>@2024 New York University Grossman School of Medicine, Weill Cornell Medicine</p>
<!--<p>Privacy Policy | Terms of Service | Cookie Policy</p>-->
</footer>
<title>Interleukin-1 blockade overcomes erlotinib resistance in head and neck squamous cell carcinoma.-DermPath</title>
<div class="content-container"> <div class="figures-container"> <div class="image-side"> <img alt="Interleukin-1 blockade overcomes erlotinib resistance in head and neck squamous cell carcinoma." class="clickable-image" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b0af/5342798/880e697cfcc6/oncotarget-07-76087-g006.jpg"/> </div> <div class="text-side"> <h1>Interleukin-1 blockade overcomes erlotinib resistance in head and neck squamous cell carcinoma.</h1> <p>Histopathology and immunostaining of tumor sections from ER-SQ20B xenograftsLow (100x) and high (insets; 200x) magnification images were taken of formalin fixed paraffin embedded tumor sections of ER-SQ20B xenografts harvested from mice treated with water (Con), anakinra (Ana), erlotinib (Erl) or anakinra+erlotinib (Ana+Erl) after staining with Hematoxylin and Eosin (H&amp;E), F4/80, myeloperoxidase (MPO), Ki67 and CD31. Semi-quantitative scoring was assigned for F4/80 staining B., and semi-quantitative scoring of peri-tumoral regions was assigned for MPO stained sections C. Ki67 staining was quantified using ImageJ software. Percentage Ki67 positive cells are represented by (Ki67-positive cells/total cells in FOV) x 100 D. Percentage of CD31 staining was quantified by Aperio slide scanner technology E. Each image is a representative of 3 tumor sections per group. All semi-quantitative and quantitative scoring was performed on 3 tumor sections per group. Error bars represent standard error of mean. S.Q. = semi quantitative.</p> <p>PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/27738319/" target="_blank">27738319</a></p><p>Type: Premalignant/Malignant, Category: Keratinocytic</p>
</div> </div></div></body></html>